ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
Pulpfiction
|
58 |
17K |
0 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
58
|
17K
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
1 |
21/06/23 |
21/06/23 |
General
|
11K
|
4.1M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders
|
|
Pulpfiction
|
95 |
27K |
3 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
95
|
27K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders
|
|
Pulpfiction
|
95 |
27K |
14 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
95
|
27K
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
7 |
14/06/23 |
14/06/23 |
General
|
11K
|
4.1M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
20 |
08/06/23 |
08/06/23 |
General
|
11K
|
4.1M
|
20
|
|
ASX - By Stock
|
BOT |
Re:
Ann: New Territory Licensed for Sofpironium Bromide with Kaken
|
|
Pulpfiction
|
21 |
12K |
7 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
21
|
12K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Investor Webinar
|
|
Pulpfiction
|
38 |
15K |
16 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
38
|
15K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Investor Webinar
|
|
Pulpfiction
|
38 |
15K |
8 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
38
|
15K
|
8
|
|
ASX - By Stock
|
RTR |
Re:
Ann: High impact drilling commences at the Earaheedy Project
|
|
Pulpfiction
|
41 |
22K |
1 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
41
|
22K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Price predictions
|
|
Pulpfiction
|
125 |
49K |
24 |
21/05/23 |
21/05/23 |
ASX - By Stock
|
125
|
49K
|
24
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Island receives FDA go-ahead for ISLA-101 program
|
|
Pulpfiction
|
53 |
14K |
2 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
53
|
14K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Pulpfiction
|
110 |
32K |
1 |
14/05/23 |
14/05/23 |
ASX - By Stock
|
110
|
32K
|
1
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
6 |
2.4K |
1 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
6
|
2.4K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
3 |
08/05/23 |
08/05/23 |
General
|
11K
|
4.1M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
3 |
08/05/23 |
08/05/23 |
General
|
11K
|
4.1M
|
3
|
|
ASX - By Stock
|
EMD |
Re:
News: EMD Emyria Receives firm Commitments In A Well Supported A$2.5M Placement
|
|
Pulpfiction
|
72 |
23K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
72
|
23K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: March 2023 Quarterly Update and Appendix 4C
|
|
Pulpfiction
|
18 |
7.3K |
23 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
18
|
7.3K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
Pulpfiction
|
236 |
91K |
13 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
236
|
91K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
4.0M |
5 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
10K
|
4.0M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Raises A$10 million via Institutional Placement
|
|
Pulpfiction
|
99 |
35K |
4 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
99
|
35K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
|
|
Pulpfiction
|
28 |
9.4K |
2 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
28
|
9.4K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Completion of Second Pilot Production with Birla Cellulose
|
|
Pulpfiction
|
14 |
5.7K |
0 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
14
|
5.7K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
232 |
69K |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
69K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Mid-Cycle Review Meeting Successfully Completed
|
|
Pulpfiction
|
59 |
21K |
10 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
59
|
21K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
4.0M |
2 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
10K
|
4.0M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
4.0M |
1 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
10K
|
4.0M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
4.0M |
14 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
10K
|
4.0M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Package from Cuba
|
|
Pulpfiction
|
30 |
9.2K |
4 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
30
|
9.2K
|
4
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Pulpfiction
|
1.6K |
674K |
4 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
1.6K
|
674K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
10K |
4.0M |
11 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
10K
|
4.0M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
Pulpfiction
|
559 |
187K |
32 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
187K
|
32
|
|
ASX - By Stock
|
ILA Biotech |
Re:
Banter and general chat
|
|
Pulpfiction
|
283 |
103K |
3 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
283
|
103K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
196 |
72K |
14 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
196
|
72K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
196 |
72K |
13 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
196
|
72K
|
13
|
|
ASX - By Stock
|
SOR |
Re:
Ann: SOR Achieves Ultra-Stable Voltage From Moisture
|
|
Pulpfiction
|
36 |
70K |
8 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
36
|
70K
|
8
|
|
ASX - By Stock
|
NC6 |
Re:
Nanollose Wins 2023 Cellulose Fibre Innovation of the year 2023 winner
|
|
Pulpfiction
|
9 |
3.5K |
2 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
9
|
3.5K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Continued promising results in PTX-100 TCL trial
|
|
Pulpfiction
|
60 |
25K |
4 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
60
|
25K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Secures Growth Funding
|
|
Pulpfiction
|
74 |
25K |
1 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
74
|
25K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: New Collaboration to Understand Zantrene Cardioprotection
|
|
Pulpfiction
|
88 |
32K |
2 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
88
|
32K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
25 |
8.1K |
5 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
25
|
8.1K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Press Article Correction
|
|
Pulpfiction
|
102 |
31K |
3 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
102
|
31K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
103 |
34K |
5 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
103
|
34K
|
5
|
|
ASX - By Stock
|
ILA |
Re:
Ann: ILA receives additional FDA feedback on IND for ISLA 101
|
|
Pulpfiction
|
7 |
1.9K |
5 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
7
|
1.9K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Ann: December 2022 Quarterly Update and Appendix 4C
|
|
Pulpfiction
|
14 |
8.0K |
5 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
14
|
8.0K
|
5
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Island receives FDA feedback on Phase 2a clinical study
|
|
Pulpfiction
|
20 |
6.0K |
2 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
20
|
6.0K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Proposed issue of securities - NC6
|
|
Pulpfiction
|
7 |
2.6K |
1 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Pulpfiction
|
1.6K |
674K |
2 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
1.6K
|
674K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Pulpfiction
|
11K |
4.1M |
3 |
19/12/22 |
19/12/22 |
General
|
11K
|
4.1M
|
3
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Pulpfiction
|
1.6K |
674K |
4 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
1.6K
|
674K
|
4
|
|